000 01129 a2200313 4500
005 20250512124644.0
264 0 _c19740322
008 197403s 0 0 eng d
022 _a0012-186X
024 7 _a10.1007/BF00461693
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRasch, R
245 0 0 _aCapillary fragility and doxium. A controlled clinical trial.
_h[electronic resource]
260 _bDiabetologia
_cDec 1973
300 _a483-5 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aCapillary Fragility
_xdrug effects
650 0 4 _aCapillary Permeability
_xdrug effects
650 0 4 _aCapillary Resistance
_xdrug effects
650 0 4 _aDiabetes Mellitus
_xdrug therapy
650 0 4 _aHemostatics
_xpharmacology
650 0 4 _aHumans
650 0 4 _aMiddle Aged
650 0 4 _aQuaternary Ammonium Compounds
_xpharmacology
650 0 4 _aSkin
_xblood supply
650 0 4 _aSulfonic Acids
_xpharmacology
773 0 _tDiabetologia
_gvol. 9
_gno. 6
_gp. 483-5
856 4 0 _uhttps://doi.org/10.1007/BF00461693
_zAvailable from publisher's website
999 _c4777058
_d4777058